LB Investment

LB Investment is a prominent venture capital firm founded in 1996 and based in Seoul, South Korea, with an additional office in Shanghai. The firm focuses on investing in a wide array of industries, including technology, information and communication technology, media, consumer goods, education, biology, healthcare, clean technology, and manufacturing. LB Investment targets companies primarily based in Korea and China, aiming to support innovative businesses that contribute to advancements in their respective sectors.

Dooseok Chae

Managing Director, Executive Director and Head of Growth Secondary Headquarters

Park Ki-ho

CEO, President

Past deals in South Korea

t'order

Series B in 2024
T'order is an information technology company specializing in tablet ordering and advertising platforms specifically designed for food and beverage brands. With a strong foothold in South Korea, the company has deployed over 250,000 tablets, catering to more than 25 million monthly active users. T'order's flagship service revolutionizes customer interaction by transforming data into actionable insights, enabling food and beverage establishments to enhance customer experiences and create targeted advertising opportunities. The platform goes beyond traditional digital menu capabilities, offering comprehensive solutions that promote a sustainable ecosystem for both businesses and their guests. As T'order continues to expand globally, it aims to leverage its innovative technology and data-driven approach to drive the digital transformation of the food and beverage industry.

SemiFive

Series B in 2023
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions. The company offers RISC-V Core IP and cloud-based custom SoC solutions tailored for consumer and industrial IoT applications. SemiFive has pioneered platform-based SoC design, enabling efficient implementation of innovative ideas into custom silicon through collaboration with clients. Its design platform utilizes configurable domain-specific architectures and pre-validated IP pools, providing a robust foundation for new chip designs. With a strong partnership with Samsung Foundry as a leading DSP partner, SemiFive delivers end-to-end capabilities that facilitate faster and more cost-effective custom SoC development, minimizing risks for applications such as data centers and AI-enabled IoT.

S-Alpha Therapeutics

Series B in 2023
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, founded in 2019. It focuses on researching and developing health applications and platform technologies designed to treat various diseases through digital devices. The company's product lineup includes SAT-001 for ophthalmology, SAT-002 for neurology, SAT-003 for oncology, and SAT-008 for addressing social issues. In addition to these applications, S-Alpha Therapeutics is engaged in developing therapeutic devices aimed at providing innovative treatment solutions for conditions that are challenging to address with existing medical technologies. The company strives to create a healthier and more equitable society by leveraging the intersection of biology and information technology to meet unmet medical needs.

Baum

Series A in 2022
Baum, Inc. specializes in electronic design automation (EDA) software and solutions aimed at enhancing the energy efficiency of semiconductor designs for various sectors, including automotive, mobile, networking, and servers. Founded in 2016 and headquartered in Daejeon, South Korea, the company offers tools that support power and thermal management, allowing engineering teams to optimize low-power consumption in their chip designs. Baum's technology is developed by a team of experienced professionals with backgrounds in semiconductor research and development, as well as business development. As a privately held entity, Baum focuses on providing innovative solutions that address the growing demand for energy-efficient semiconductor technologies.

t'order

Venture Round in 2022
T'order is an information technology company specializing in tablet ordering and advertising platforms specifically designed for food and beverage brands. With a strong foothold in South Korea, the company has deployed over 250,000 tablets, catering to more than 25 million monthly active users. T'order's flagship service revolutionizes customer interaction by transforming data into actionable insights, enabling food and beverage establishments to enhance customer experiences and create targeted advertising opportunities. The platform goes beyond traditional digital menu capabilities, offering comprehensive solutions that promote a sustainable ecosystem for both businesses and their guests. As T'order continues to expand globally, it aims to leverage its innovative technology and data-driven approach to drive the digital transformation of the food and beverage industry.

K Auction

Convertible Note in 2022
K Auction is a leading art auction house in South Korea, specializing in modern and contemporary Korean art. The company conducts various types of auctions, including major, special, charity, and private collection events. K Auction features works from prominent Korean and international artists, as well as traditional Korean arts and crafts, thereby providing a diverse range of artworks for collectors and enthusiasts. Through its commitment to showcasing both contemporary and traditional pieces, K Auction plays a significant role in promoting Korean art on a global scale.

IVIM Technology

Series C in 2022
IVIM Technology, Inc. specializes in the development and manufacture of advanced IntraVital Microscopy platforms and related medical devices. Based in Daejeon, South Korea, the company was founded in 2017 and focuses on live cell intravital imaging, which allows for the monitoring of drug efficacy and delivery in real-time within living organisms. Its technology enables the analysis of cellular interactions and the complex processes underlying human diseases, particularly in the context of new biopharmaceuticals, including immunological, cell, gene, and antibody therapies. IVIM Technology's services include whole tissue 3D imaging, providing comprehensive insights into drug performance at the cellular level.

SemiFive

Series B in 2022
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions. The company offers RISC-V Core IP and cloud-based custom SoC solutions tailored for consumer and industrial IoT applications. SemiFive has pioneered platform-based SoC design, enabling efficient implementation of innovative ideas into custom silicon through collaboration with clients. Its design platform utilizes configurable domain-specific architectures and pre-validated IP pools, providing a robust foundation for new chip designs. With a strong partnership with Samsung Foundry as a leading DSP partner, SemiFive delivers end-to-end capabilities that facilitate faster and more cost-effective custom SoC development, minimizing risks for applications such as data centers and AI-enabled IoT.

Organoid Sciences

Series B in 2022
Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.

Plasmapp

Venture Round in 2021
Plasmapp Co. Ltd., established in 2015 and headquartered in Daejeon, South Korea, specializes in plasma engineering technology. The company has developed advanced plasma curing and sterilization systems, including PMPS, a versatile atmospheric plasma equipment designed for producing plasma-treated water and sterilizing medical devices. Additionally, Plasmapp offers PNCM, a precise in-situ NOx concentration monitoring system. The company has pioneered the use of plasma technology for the curing of processed meat, marking a significant innovation in the field. Alongside these products, Plasmapp has created a plasma sterilizer for medical tools, known as STERPACK packaging pouches. With its roots in research from KAIST, Plasmapp aims to provide effective engineering solutions to meet diverse industry needs.

Sky Labs

Series B in 2021
Sky Labs is focused on developing innovative wearable technology for continuous health monitoring, specifically targeting atrial fibrillation, a common but often undiagnosed heart condition. The company’s flagship product, the Cardio Tracker (CART), is a cuffless, ring-type device that allows users to monitor their heart health effortlessly by simply wearing it on their finger. This device is designed to be comfortable and practical for daily use, being waterproof and dustproof so that it can be worn continuously, even during activities like showering. The CART operates without requiring user intervention, automatically detecting and recording instances of atrial fibrillation to provide users with real-time health data accessible via a smartphone app. This capability not only helps users manage their heart health but also assists healthcare professionals in diagnosing atrial fibrillation based on the data collected. Sky Labs is currently engaged in clinical trials with Seoul National University Hospital to validate the device's performance and is collaborating with Bayer to enhance its healthcare offerings. The initial target market includes atrial fibrillation patients in Finland, with a broader goal of reaching millions globally.

Barogo

Series C in 2021
Barogo provides a last-mile delivery platform to clients in order to generate new and creative business opportunities. It focuses on the ecosystem of connectivity and connects all possible businesses and customers. It was founded in 2014 and is based in Seoul, South Korea.

Musicow

Series C in 2021
Musicow, Inc. operates an online platform that facilitates investment in music copyrights, specifically K-Pop songs, by allowing fans to buy and sell stakes in these copyrights. Founded in 2017 and based in Seoul, South Korea, the platform enables users to bid on music creations through public auctions and a secondary marketplace. Investors can earn royalties based on the streaming and usage of the songs, thereby participating in the music industry while potentially achieving financial returns. Musicow's innovative approach connects musical artists with fans and investors, creating a unique ecosystem for music project financing and copyright sharing.

Standigm

Series C in 2021
Standigm, Inc. is a South Korean company specializing in artificial intelligence technologies for the pharmaceutical industry, founded in 2015. It focuses on AI-driven drug discovery, employing its proprietary platforms to streamline the process from target identification to lead generation. Standigm's workflow automates molecular design through its DarkMolFactory™ and encompasses a full-stack approach to drug discovery with tools such as Standigm ASK™ for target identification, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing. By leveraging advanced data analysis techniques, Standigm aims to enhance the efficiency of drug development, reducing both time and costs for pharmaceutical companies in bringing new drugs to market.

Elice

Series B in 2020
Elice Inc. is a South Korean company based in Daejeon that specializes in digital education through an online platform. The company offers a variety of courses focused on web application development and programming languages such as C++, Python, and Java. Elice's educational approach is centered on employee digital transformation training, featuring a structured process that includes training, evaluation, and recruitment. This enables students to engage in practice-based learning, where they can tackle real-world problems in a simulated environment. Additionally, the platform leverages artificial intelligence to enhance the learning experience, providing features like live coding and immediate feedback to help students improve their skills in algorithmic coding and beyond.

bitsensing

Seed Round in 2020
Bitsensing is a radar technology startup based in Seoul, South Korea, founded in 2018. The company specializes in developing innovative products and solutions that enhance smart city infrastructure and improve quality of life for citizens. Its offerings include the Traffic Radar, which provides real-time monitoring of traffic conditions such as vehicle counts and speeds, and the Virtual Fence, a device that detects intrusions without the need for physical barriers. Additionally, Bitsensing has developed a 4D Imaging Radar that supports autonomous driving through high-resolution, point-cloud-based detection and tracking capabilities. By integrating artificial intelligence with radar technology, Bitsensing aims to create reliable environments and promote smart living solutions.

Fount

Series B in 2020
Fount Inc. is an asset management Robo-Advisor company established in 2015 and headquartered in Seoul, South Korea. The firm specializes in providing customized financial portfolios through its advanced Robo-Advisor engine, Bluewhale, which utilizes AI technology and asset allocation theories to determine the optimal mix of assets. Fount's investing algorithm, driven by big data, assists clients in planning for various life events by promoting passive investing strategies that align with individual risk tolerance and time horizons. The company's tools enable clients to monitor financial markets and adjust their asset allocations in response to market fluctuations.

Musicow

Series B in 2020
Musicow, Inc. operates an online platform that facilitates investment in music copyrights, specifically K-Pop songs, by allowing fans to buy and sell stakes in these copyrights. Founded in 2017 and based in Seoul, South Korea, the platform enables users to bid on music creations through public auctions and a secondary marketplace. Investors can earn royalties based on the streaming and usage of the songs, thereby participating in the music industry while potentially achieving financial returns. Musicow's innovative approach connects musical artists with fans and investors, creating a unique ecosystem for music project financing and copyright sharing.

Organoid Sciences

Series A in 2020
Organoid Sciences is a drug development company based in Seongnam-si, South Korea, founded in 2018. The company specializes in organoid-based treatments and utilizes cannabinoid-based technology to create drugs aimed at addressing various incurable diseases. In addition to drug development, Organoid Sciences provides drug screening services and focuses on regenerative medicine, contributing to advancements in healthcare solutions.

StyleShare

Series D in 2020
StyleShare Inc. is a mobile and web application developed for users to share and discover information related to fashion, beauty, and lifestyle. Founded in 2011 and based in Seoul, South Korea, the platform has attracted millions of users across 120 countries, establishing itself as a leading source for everyday fashion and beauty insights. Users can share their outfits, purchases, and receive updates, fostering a community centered around fashion discovery. StyleShare has received notable recognition from prominent publications such as VOGUE and Elle Japan, solidifying its status as a top mobile application in the fashion sector.

Standard Energy

Venture Round in 2019
Standard Energy is a South Korea-based technology startup that specializes in the development of vanadium ion batteries, aiming to transform the current lithium-ion energy storage landscape. The company focuses on creating an energy storage system that enhances operational stability and prolongs battery performance. Utilizing proprietary redox flow technology, Standard Energy offers a safe and cost-effective alternative to conventional batteries. This innovative approach enables clients to achieve long-term stable operation, even in challenging environments.

Blocko

Series B in 2019
Blocko Inc. is a blockchain technology company based in Seongnam, South Korea, established in 2014. The firm specializes in developing solutions that facilitate the adoption of blockchain technology across various sectors, targeting freelancers, startups, and large enterprises. Its flagship product, CoinStack, is a Backend-as-a-Service platform that enables customers to design, deploy, and manage digital services on a secure distributed network through user-friendly application programming interfaces (APIs). Additionally, Blocko offers software development kits (SDKs), application monitoring tools, and technical support to enhance user experience and application performance. The company also supports AERGO, an open-source enterprise blockchain solution that features a hybrid design and advanced cloud deployment capabilities. Through its comprehensive offerings, Blocko aims to improve security, transparency, and efficiency in digital transactions and services.

D&D Pharmatech

Series B in 2019
D&D Pharmatech Co., Ltd. is a clinical-stage global biotech company based in Seongnam, South Korea, founded in 2014. The company focuses on developing therapeutic medicines for various indications, including neurodegenerative diseases, metabolic disorders, fibrotic diseases, and molecular imaging and radiotherapy. D&D Pharmatech operates as a holding company, funding the development of disease-specific subsidiaries led by esteemed medical research faculty. Its product pipeline aims to translate advanced research into effective therapeutic solutions. The company also engages in specialized projects such as developing positron emission tomography (PET) imaging biomarkers through its subsidiary, Precision Molecular Inc., and single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. D&D Pharmatech employs innovative drug delivery technologies, including PEGylation, to enhance treatment efficacy and patient outcomes.

Standigm

Series B in 2019
Standigm, Inc. is a South Korean company specializing in artificial intelligence technologies for the pharmaceutical industry, founded in 2015. It focuses on AI-driven drug discovery, employing its proprietary platforms to streamline the process from target identification to lead generation. Standigm's workflow automates molecular design through its DarkMolFactory™ and encompasses a full-stack approach to drug discovery with tools such as Standigm ASK™ for target identification, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing. By leveraging advanced data analysis techniques, Standigm aims to enhance the efficiency of drug development, reducing both time and costs for pharmaceutical companies in bringing new drugs to market.

DAILYHOTEL

Series C in 2018
DAILYHOTEL is a lifestyle technology enabler that provides affordable access to quality experiences in accommodation, dining and travel offerings through its mobile platform. They focus on transaction through mobile app only, selling more than 100,000 room every month on average in just South Korea alone. In 2017 March, they have reached over 7million downloads for their app.

EOFlow

Series C in 2018
EOFlow Co., Ltd. is a South Korean company that specializes in drug delivery solutions, focusing primarily on the development and manufacturing of wearable insulin pumps. Its flagship product, EOPatch, is recognized as the world's smallest full-featured disposable insulin pump. This innovative device is designed to be smarter, better-connected, and longer-lasting than its competitors, while also being more cost-effective. EOFlow is also enhancing the EOPatch with software upgrades that will enable closed-loop insulin control, effectively functioning as an automated insulin delivery system. Additionally, the company is working on an all-in-one wearable disposable artificial pancreas solution, which has received Breakthrough Device designation from the FDA, highlighting its potential to significantly impact diabetes management.

Awair

Venture Round in 2018
Awair is a company dedicated to improving indoor air quality (IAQ) for individuals in various environments, including homes, schools, and workplaces. Headquartered in San Francisco, with an additional office in Seoul, Awair develops advanced indoor air monitoring devices that measure key factors such as temperature, humidity, carbon dioxide, volatile organic compounds, and dust. These devices provide users with actionable insights and easy-to-understand software, empowering them to enhance their indoor air quality for better health and safety. By focusing on user-friendly technology and comprehensive monitoring, Awair aims to ensure that people can breathe safely indoors.

D&D Pharmatech

Series A in 2018
D&D Pharmatech Co., Ltd. is a clinical-stage global biotech company based in Seongnam, South Korea, founded in 2014. The company focuses on developing therapeutic medicines for various indications, including neurodegenerative diseases, metabolic disorders, fibrotic diseases, and molecular imaging and radiotherapy. D&D Pharmatech operates as a holding company, funding the development of disease-specific subsidiaries led by esteemed medical research faculty. Its product pipeline aims to translate advanced research into effective therapeutic solutions. The company also engages in specialized projects such as developing positron emission tomography (PET) imaging biomarkers through its subsidiary, Precision Molecular Inc., and single-cell sequencing related to degenerative brain diseases via Valted Seq, Inc. D&D Pharmatech employs innovative drug delivery technologies, including PEGylation, to enhance treatment efficacy and patient outcomes.

Orum Therapeutics

Series A in 2017
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.

Bagelcode

Series B in 2017
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, that specializes in developing social casino games. Founded in 2012, the company has built a global presence, attracting over 170 members from various countries, including South Korea, the United States, and the United Kingdom. With more than 45 million users worldwide, Bagelcode focuses on creating an engaging gaming experience that allows players to enjoy casino games like slots and poker on both web and mobile platforms. The company emphasizes the importance of individual growth for collective success, fostering a diverse team of talented professionals from top universities and countries. Since its inception, Bagelcode has demonstrated substantial growth, launching multiple successful titles and continuously seeking new talent to achieve its goal of becoming a leading global gaming company.

Market Kurly

Series A in 2016
Market Kurly is an online grocery service based in Seoul, South Korea, that specializes in the delivery of fresh and premium food products. Founded in 2014, the platform allows users to order a wide range of items, including vegetables, fruits, meats, dairy, baked goods, and processed foods, all sourced directly from producers. Market Kurly focuses on providing high-quality ingredients and offers next-day delivery, ensuring that customers receive their orders promptly. The service also includes non-perishable items, enabling shoppers to conveniently access a variety of groceries. Through its innovative logistics and delivery system, Market Kurly aims to enhance the grocery shopping experience by transforming the way food is produced and distributed.

Awair

Series A in 2016
Awair is a company dedicated to improving indoor air quality (IAQ) for individuals in various environments, including homes, schools, and workplaces. Headquartered in San Francisco, with an additional office in Seoul, Awair develops advanced indoor air monitoring devices that measure key factors such as temperature, humidity, carbon dioxide, volatile organic compounds, and dust. These devices provide users with actionable insights and easy-to-understand software, empowering them to enhance their indoor air quality for better health and safety. By focusing on user-friendly technology and comprehensive monitoring, Awair aims to ensure that people can breathe safely indoors.

Standigm

Series A in 2016
Standigm, Inc. is a South Korean company specializing in artificial intelligence technologies for the pharmaceutical industry, founded in 2015. It focuses on AI-driven drug discovery, employing its proprietary platforms to streamline the process from target identification to lead generation. Standigm's workflow automates molecular design through its DarkMolFactory™ and encompasses a full-stack approach to drug discovery with tools such as Standigm ASK™ for target identification, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing. By leveraging advanced data analysis techniques, Standigm aims to enhance the efficiency of drug development, reducing both time and costs for pharmaceutical companies in bringing new drugs to market.

AptaBio Therapeutics

Series B in 2016
AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, that specializes in the discovery and development of selective inhibitors targeting the NOX family of enzymes, as well as aptamer-based anti-cancer drugs. The company's product offerings include a range of transfection reagents designed for DNA or RNA delivery into eukaryotic cells. AptaBio is advancing several product candidates aimed at addressing significant health issues, including PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 for non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics focuses on creating innovative solutions for complex medical challenges.

NHN Edu

Series A in 2015
NHN Edu Corp. is an online educational services provider based in Seongnam, South Korea. The company specializes in designing and developing web and mobile platforms for education, including IMS School, IMT, Union, and Pink Diary. NHN Edu's class management platform supports teachers in organizing classes, tracking student behavior, and facilitating communication with parents. This functionality aims to enhance the learning environment and promote student growth.

Iamcompany

Series B in 2015
Iamcompany is a student startup affiliated with the KAIST Midam committee, focusing on enhancing educational opportunities through internet-based technologies. With an investment of 2 billion won from various investors, the company aims to identify and develop students' potential. Its primary services include the mobile app 'iamschool,' which delivers news and updates from educational institutions to caregivers, allowing them to follow and engage with schools similarly to social media platforms. Additionally, the web service 'iamclass' provides direct information about students and institutions to caregivers while also serving as an advertising channel for educational entities. Through these platforms, Iamcompany seeks to foster a more conducive learning environment for students in South Korea.

FraSen

Seed Round in 2015
FraSen Inc. is a sleep monitoring start-up based in Seoul, South Korea, that specializes in personalized sleep care solutions. The company integrates sleep science with internet of things (IoT) technology and software to enhance sleep quality. Its flagship product, the Neurofeedback Sleep Mask, utilizes neuroscience principles to measure brain waves and monitor sleep stages. The device employs sound and light stimulation to help users transition from light to deep sleep. In addition to hardware, FraSen provides a tailored software service designed to boost energy, improve performance, and promote relaxation, ultimately enabling users to achieve deeper, more restorative sleep. Established in 2010, FraSen has attracted investment from FastTrackAsia.

KoKomo Games

Series A in 2015
Kokomo Games is a gaming studio based in Seoul, South Korea, established in 2014. The company specializes in designing and developing massively multiplayer online role-playing games (MMORPGs). With a team of experienced professionals who have previously contributed to significant titles like "Lineage2" and "Blade&Soul," Kokomo aims to carve out a niche in the hardcore RPG genre, which they view as an untapped market. Unlike the current trend towards trading card games and midcore RPGs, Kokomo is focused on creating a flagship mobile MMORPG that appeals to gamers in Asia, particularly those with interests similar to the Korean gaming community. The studio's mission is to enhance the gaming experience by developing interactive, narrative-driven games that support multiplayer engagement in real-time.

ZigBang

Venture Round in 2015
ZigBang Co., Ltd. is a South Korean company founded in 2010, specializing in a property listing platform that connects real estate agents with renters. The company offers a user-friendly marketplace for apartment hunting through its mobile and web applications, allowing users to search for rental properties based on criteria such as the number of rooms, occupants, and price. ZigBang has reported approximately 6 million users, although this figure includes both active and inactive accounts. The platform aims to simplify the rental process and help users make informed choices while potentially saving money on housing.

The Beatpacking Company

Series B in 2015
The Beatpacking Company is a prominent provider of ad-supported music streaming services in South Korea, offering a mobile application known as BEAT. This platform allows users to access a diverse range of music tailored to their genre preferences, enhancing the listening experience through social features. By focusing on mobile devices and smartphones, The Beatpacking Company caters to the growing demand for music streaming in a mobile-centric environment, establishing itself as a leader in the South Korean music streaming market.

Noom

Series B in 2014
Noom, Inc. is a digital health company that specializes in mobile health coaching solutions aimed at helping individuals manage and prevent chronic conditions such as obesity, diabetes, and hypertension. Founded in 2008 and headquartered in New York City, Noom offers a psychology-based platform that integrates evidence-based curricula with trained cognitive behavior coaches, mobile tracking, and scalable coaching tools. The platform empowers users to achieve their personal health and wellness goals, including weight management and stress reduction. Noom has received multiple grants from the National Institutes of Health and is recognized as a certified diabetes prevention program by the Centers for Disease Control. In addition to serving individual users, Noom also partners with businesses to promote health and wellness initiatives. The company has additional offices in Seoul, South Korea, and Tokyo, Japan.

Wider Planet

Series C in 2014
Wider Planet Inc. operates advertising platforms in South Korea and internationally, focusing on analyzing digital users' preferences and interests through big data. The company offers a range of services, including display advertising, mobile advertising, and app advertising, along with campaign planning, management, and performance analysis. Its technology includes a demand-side platform that categorizes users to meet client needs, a data management platform for collecting and analyzing behavioral data, a real-time bidding platform, and an SSP advertising tool. Founded in 2010 and based in Seoul, South Korea, Wider Planet aims to deliver optimal, targeted marketing and advertisement content to enhance client engagement and effectiveness.

StyleShare

Series B in 2014
StyleShare Inc. is a mobile and web application developed for users to share and discover information related to fashion, beauty, and lifestyle. Founded in 2011 and based in Seoul, South Korea, the platform has attracted millions of users across 120 countries, establishing itself as a leading source for everyday fashion and beauty insights. Users can share their outfits, purchases, and receive updates, fostering a community centered around fashion discovery. StyleShare has received notable recognition from prominent publications such as VOGUE and Elle Japan, solidifying its status as a top mobile application in the fashion sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.